My Policy Hub

Improving health is our policy

  • Dashboard
  • Impact Insights
  • Issues
  • ACA Now
  • Search
  • Contact
  • Dashboard
  • Impact Insights
  • Issues
  • ACA Now
  • Search
  • Contact

ACA Now

4003 - Clinical and Community Preventive Services

 
Implementation Status 
Statutory Text 

Summary

Clarifies and expounds upon the role of the existing United States Preventive Services Task Force (USPSTF), directing the USPSTF to, among other things, review interventions and update recommendations related to certain topic areas, including new or improved techniques to assess the health effects of such interventions, at least once during every five-year period.

Provides for the coordination of the USPSTF with the Community Preventive Services Task Force (CPSTF) and the Advisory Committee on Immunization Practices (ACIP).

With respect to the newly established CPSTF, which is overseen by the CDC, stipulates that such group must, among other things, at least once during every five-year period, review interventions and update recommendations related to certain topic areas, including new or improved techniques to assess the health effects of interventions, including health impact assessment and population health modeling.

Authorizes (but does not appropriate) such sums as may be necessary to carry out the activities of the USPSTF and the CPSTF, respectively.

Last updated: (May 9, 2016)  #Prevention, #Public Health

Implementation Status

 
Summary 
Statutory Text 

2013

Prior to January 2013, the USPSTF and CPSTF continued to coordinate and provide complimentary (but different) prevention-oriented, evidence-based recommendations based on scientific reviews, with AHRQ and CDC staff involvement.  To view the official collection of all CPSTF findings and the systematic reviews on which they are based, visit The Community Guide’s website (or see here).

More information specific to the coordination of USPSTF and CPSTF efforts is available here.  The Surgeon General’s website also has more information about the activities of the CPSTF.  For further details regarding the efforts of the ACIP, including meeting information and recommendations, see the CMS webpage dedicated to this effort.

In a related note, in early 2013, AHRQ released its Guide to Clinical Preventive Services, which serves as a pocket guide for practitioners and others, and includes USPSTF recommendations on screening, counseling, and preventive medication topics and includes clinical considerations for each topic.  For details, see here.

See also related FAQ, issued on February 20, 2013 by CCIIO, on coverage of preventive health services as it pertains to Title I provisions.

On a related note, on April 17, 2013, AHRQ posted a notice in which it solicits nominations of individuals qualified to serve as members of the U.S. Preventive Services Task Force (USPSTF).  As the notice points out, all nominations must be received by May 15, 2013 to be considered for appointment to begin January 1, 2014.

2014

On March 19, 2014, AHRQ announced the appointments of Drs. Michael L. LeFevre and Kirsten Bibbins-Domingo as chair and co-vice chair, respectively, of the USPSTF.

On Sept. 25, the CDC announced the award of $212 million in Fiscal Year (FY) 2014 grants to support chronic disease prevention and health promotion initiatives across the country. The 193 total awards announced today, which are supported in part through Affordable Care Act (ACA) funds, will be used by states, localities, national and community organizations, and other eligible entities to focus on the following 3 broad goals: (1) reduce rates of death and disability due to tobacco use; (2) reduce prevalence of obesity; and (3) reduce rates of death and disability due to diabetes, heart disease, and stroke.

2015

On Mar. 20, AHRQ issued a solicitation for nominations to serve a four-year term on the USPSTF. To be considered for an appointment beginning Jan. 2016, nominations should be received by May 15.

2016

On Feb. 8, AHRQ announced the appointment of four new members to the U.S. Preventive Services Task Force (USPSTF), namely: (1) John W. Epling, Jr., M.D., M.S.Ed.; (2) Diane Medved Harper, M.D., M.P.H., M.S.; (3) C. Seth Landefeld, M.D.; and (4) Carol M. Mangione, M.D., M.S.P.H.

On April 1, the AHRQ issued a request for nominations for members of the U.S. Preventative Services Task Force (USPSTF). Nominations are due by May 15, 2016; appointments will begin in January 2017.

On May 26, the USPSTF posted a draft research plan on screening for intimate partner violence and abuse of elderly and vulnerable adults. The draft research plan is available for public comment through June 22, 2016.

2017

In May, CDC announced the opening of the nomination period for members of the Community Preventive Services Task Force (CPSTF) to serve 5-year terms starting in 2018 or 2019. Details.

2018

In February, AHRQ invited nominations of individuals qualified to serve as members of the U.S. Preventive Services Task Force (USPSTF), beginning in January 2019. Details.

2019

In February, AHRQ announced it was seeking nominations of individuals qualified to serve as members of the U.S. Preventive Services Task Force (USPSTF), beginning in January, 2020. Details.

In November, USPSTF released its “Ninth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services.” Details.

In December, CDC issued a request for information to identify priority topics for the Community Preventive Services Task Force (CPSTF) to guide its work over the next five years. Details.

2020

In January, AHRQ issued a request for nominations for the U.S. Preventive Services Taskforce (USPSTF) for appointments set to begin January 2021. Details.

Statutory Text

 
Implementation Status 
Summary 

SEC. 4003. CLINICAL AND COMMUNITY PREVENTIVE SERVICES.

(a) PREVENTIVE SERVICES TASK FORCE.—Section 915 of the Public Health Service Act (42 U.S.C. 299b–4) is amended by striking subsection (a) and inserting the following: ‘‘(a) PREVENTIVE SERVICES TASK FORCE.— ‘‘(1) ESTABLISHMENT AND PURPOSE.—The Director shall convene an independent Preventive Services Task Force (referred to in this subsection as the ‘Task Force’) to be composed of individuals with appropriate expertise. Such Task Force shall review the scientific evidence related to the effectiveness, appropriateness, and cost-effectiveness of clinical preventive services for the purpose of developing recommendations for the health care community, and updating previous clinical preventive recommendations, to be published in the Guide to Clinical Preventive Services (referred to in this section as the ‘Guide’), for individuals and organizations delivering clinical services, including primary care professionals, health care systems, professional societies, employers, community organizations, nonprofit organizations, Congress and other policy-makers, governmental public health agencies, health care quality organizations, and organizations developing national health objectives.Such recommendations shall consider clinical preventive best practice recommendations from the Agency for Healthcare Research and Quality, the National Institutes of Health, the Centers for Disease Control and Prevention, the Institute of Medicine, specialty medical associations, patient groups, and scientific societies. ‘‘(2) DUTIES.—The duties of the Task Force shall include— ‘‘(A) the development of additional topic areas for new recommendations and interventions related to those topic areas, including those related to specific sub-populations and age groups; ‘‘(B) at least once during every 5-year period, review interventions and update recommendations related to existing topic areas, including new or improved techniques to assess the health effects of interventions; ‘‘(C) improved integration with Federal Government health objectives and related target setting for health improvement; ‘‘(D) the enhanced dissemination of recommendations; ‘‘(E) the provision of technical assistance to those health care professionals, agencies and organizations that request help in implementing the Guide recommendations; and ‘‘(F) the submission of yearly reports to Congress and related agencies identifying gaps in research, such as preventive services that receive an insufficient evidence statement, and recommending priority areas that deserve further examination, including areas related to populations and age groups not adequately addressed by current recommendations. ‘‘(3) ROLE OF AGENCY.—The Agency shall provide ongoing administrative, research, and technical support for the operations of the Task Force, including coordinating and supporting the dissemination of the recommendations of the Task Force, ensuring adequate staff resources, and assistance to those organizations requesting it for implementation of the Guide’s recommendations. ‘‘(4) COORDINATION WITH COMMUNITY PREVENTIVE SERVICES TASK FORCE.—The Task Force shall take appropriate steps to coordinate its work with the Community Preventive Services Task Force and the Advisory Committee on Immunization Practices, including the examination of how each task force’s recommendations interact at the nexus of clinic and community. ‘‘(5) OPERATION.—Operation. In carrying out the duties under paragraph (2), the Task Force is not subject to the provisions of Appendix 2 of title 5, United States Code. ‘‘(6) INDEPENDENCE.—All members of the Task Force convened under this subsection, and any recommendations made by such members, shall be independent and, to the extent practicable, not subject to political pressure. ‘‘(7) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to be appropriated such sums as may be necessary for each fiscal year to carry out the activities of the Task Force.’’. (b) COMMUNITY PREVENTIVE SERVICES TASK FORCE.— (1) IN GENERAL.—Part P of title III of the Public Health Service Act, as amended by paragraph (2), is amended by adding at the end the following: ‘‘SEC. 399U ø42 U.S.C. 280g–10¿. COMMUNITY PREVENTIVE SERVICES TASK FORCE. ‘‘(a) ESTABLISHMENT AND PURPOSE.—The Director of the Centers for Disease Control and Prevention shall convene an independent Community Preventive Services Task Force (referred to in this subsection as the ‘Task Force’) to be composed of individuals with appropriate expertise. Such Task Force shall review the scientific evidence related to the effectiveness, appropriateness, and cost-effectiveness of community preventive interventions for the purpose of developing recommendations, to be published in the Guide to Community Preventive Services (referred to in this section as the ‘Guide’), for individuals and organizations delivering population-based services, including primary care professionals, health care systems, professional societies, employers, community organizations, non-profit organizations, schools, governmental public health agencies, Indian tribes, tribal organizations and urban Indian organizations, medical groups, Congress and other policymakers. Community preventive services include any policies, programs, processes or activities designed to affect or otherwise affecting health at the population level. ‘‘(b) DUTIES.—The duties of the Task Force shall include— ‘‘(1) the development of additional topic areas for new recommendations and interventions related to those topic areas, including those related to specific populations and age groups, as well as the social, economic and physical environments that can have broad effects on the health and disease of populations and health disparities among sub-populations and age groups; ‘‘(2) at least once during every 5-year period, review interventions and update recommendations related to existing topic areas, including new or improved techniques to assess the health effects of interventions, including health impact assessment and population health modeling; ‘‘(3) improved integration with Federal Government health objectives and related target setting for health improvement; ‘‘(4) the enhanced dissemination of recommendations; ‘‘(5) the provision of technical assistance to those health care professionals, agencies, and organizations that request help in implementing the Guide recommendations; and ‘‘(6) providing yearly reports to Congress and related agencies identifying gaps in research and recommending priority areas that deserve further examination, including areas related to populations and age groups not adequately addressed by current recommendations. ‘‘(c) ROLE OF AGENCY.—The Director shall provide ongoing administrative, research, and technical support for the operations of the Task Force, including coordinating and supporting the dissemination of the recommendations of the Task Force, ensuring adequate staff resources, and assistance to those organizations requesting it for implementation of Guide recommendations. ‘‘(d) COORDINATION WITH PREVENTIVE SERVICES TASK FORCE.— The Task Force shall take appropriate steps to coordinate its work with the U.S. Preventive Services Task Force and the Advisory Committee on Immunization Practices, including the examination of how each task force’s recommendations interact at the nexus of clinic and community. ‘‘(e) OPERATION.—In carrying out the duties under subsection (b), the Task Force shall not be subject to the provisions of Appendix 2 of title 5, United States Code. ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to be appropriated such sums as may be necessary for each fiscal year to carry out the activities of the Task Force.’’. (2) TECHNICAL AMENDMENTS.— (A) Section 399R of the Public Health Service Act (as added by section 2 of the ALS Registry Act (Public Law 110–373; 122 Stat. 4047)) is redesignated as section 399S. (B) Section 399R of such Act (as added by section 3 of the Prenatally and Postnatally Diagnosed Conditions Awareness Act (Public Law 110–374; 122 Stat. 4051)) is redesignated as section 399T.

Browse ACA Titles

  • I-Quality, Affordable Health Care for all Americans
  • II-Role of Public Programs
  • III-Improving the Quality and Efficiency of Health Care
  • IV-Prevention of Chronic Disease and Improving Public Health
  • V-Health Care Workforce
  • VI-Transparency and Program Integrity
  • VII-Improving Access to Innovative Medical Therapies
  • VIII-Community Living Assistance Services and Supports (CLASS ACT)
  • IX-Revenue Provisions

ABOUT

  • Home
  • About Policy Hub
  • Free Newsletter
  • Team
  • Mission and Values
  • Contact Us

Contact Us

Impact Health Policy Partners 1301 K Street, NW, Suite 300W
Washington, D.C. 20005

(202) 309-0796
Contact Us

Copyright © 2025 ‐ Impact Health Policy Partners ‐ All Rights Reserved ‐ Privacy Policy ‐ Terms and Conditions ‐ Log in